Blood donor: Why I give at MD Anderson
Growing up, Ross Robinson knew the type O-negative blood he and his family shared was special.
"I'm a universal donor, so I know I...
Clinical trial explores drug repurposing for non-small cell...
Over the last decade, the three-year survival rate for lung cancer has increased dramatically. That means more people are living...
Metastatic melanoma survivor grateful for immunotherapy...
Last updated March 18, 2022.
When Bob Seibert reflects on the nearly one and half years since his stage IV melanoma diagnosis...
A community-based approach to cancer prevention and wellness
“Every community is unique,” says Ruth Rechis, Ph.D., director of Be Well Communities™, MD Anderson’s place-based strategy for cancer...
